Stocks and Investing
by (remove) : Mark Massaro
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Mark Massaro
RSSJSONXMLCSV
Wed, October 2, 2024
Tue, September 10, 2024
Mon, August 12, 2024
Tue, August 6, 2024
Wed, July 31, 2024
Thu, July 25, 2024
Wed, June 26, 2024
Thu, May 16, 2024
Tue, May 14, 2024
Tue, April 30, 2024
Mon, April 22, 2024
Thu, April 4, 2024
Tue, March 12, 2024
Wed, March 6, 2024
Thu, August 10, 2023
Thu, May 18, 2023
Mon, April 24, 2023
Wed, March 22, 2023
Fri, March 10, 2023
Tue, February 28, 2023
Sun, February 5, 2023
Tue, January 3, 2023
Mon, December 12, 2022
Thu, November 17, 2022
Mon, November 7, 2022
Thu, July 7, 2022
Wed, June 22, 2022
Wed, February 16, 2022
Thu, October 8, 2020

Mark Massaro Maintained (ADPT) at Strong Buy with Increased Target to $8 on, Oct 2nd, 2024


Published on 2024-10-28 14:35:21 - WOPRAI, Mark Massaro
  Print publication without navigation


Mark Massaro of BTIG, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Strong Buy with Increased Target from $7 to $8 on, Oct 2nd, 2024.

Mark has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, 0 agree with Mark's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mark


  • Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Increased Target to $6 on, Friday, August 2nd, 2024
Contributing Sources